Products for Research Use Only
RegisterLogin

Vemzatatug

CAT: 0804-HY-P991726Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P991726Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Vemzatatug is a humanized IgG1κ monoclonal antibody inhibitor targeting GPRC5D. Vemzatatug has an antitumor activity. Vemzatatug can be used for cancers like multiple myeloma (MM) research[1][2].
CAS Number
3035714-52-1
UNSPSC
12352100
Target
Orphan GPCR
Related Pathways
GPCR/G Protein
Applications
Cancer-programmed cell death
Field of Research
Cancer
References & Citations
[1]Rodriguez-Otero P, et al. GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review. Blood Cancer J. 2024 Feb 2;14 (1) :24. doi: 10.1038/s41408-023-00966-9. Erratum in: Blood Cancer J. 2024 Mar 6;14 (1) :40. |[2]Internacionales D C. International Nonproprietary Names for Pharmaceutical Substances (INN) [J]. WHO Drug Information, 2025, 39 (2) .
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported

Alternative Products

CatalogName
T9901A-1859-01Vemzatatug
WA3768Research Grade vemzatatug
GTR18776786-01Research Grade vemzatatug Antibody
PX-TA2523-01Vemzatatug Biosimilar - Research Grade
HP458056-01Anti-Human GPRC5D Reference Antibody (Vemzatatug, RUO)

Popular Products